TrialOpen forum infectious diseases2026

Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5-6 Years After Primary Vaccination in Adults ≥50 Years.

Rafael Leon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.